VYSTAR CORPORATION (OTCMKTS:VYST) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07
The Annual Meeting of the Company’s Shareholders was held on August 11, 2017. Matters submitted to the shareholders and voted upon at the meeting, which are more fully described in the Company’s proxy statement, are as follows: (1) election of three members to the Board of Directors for terms ending at the 2019 annual meeting of shareholders; and (2) ratification of the appointment of Porter Keadle Moore, LLC, as independent registered public accounting firm for the year ending December 31, 2017.
The following is a summary of the votes cast for and against as to each proposal, including a separate tabulation with respect to each nominee for director.
| FOR | AGAINST | ABSTAIN/WITHOLD | ||||
| PROPOSALS | VOTES | % of O/S Voting | VOTES | % of OS Voting Power | VOTES | % of O/S Voting Power |
| Proposal 1 | ||||||
| WILLIAM R. DOYLE AS DIRECTOR | 68,878,000 | 56.35% | 109,798 | 0.09% | 1,000 | 0.00% |
| MITSY Y. MAGNUM AS DIRECTOR | 68,978,800 | 56.43% | 9,798 | 0.01% | 1,000 | 0.00% |
| MICHAEL X. IANACONE AS DIRECTOR | 68,978,800 | 56.43% | 9,798 | 0.01% | 1,000 | 0.00% |
| Proposal 2 | ||||||
| PORTER KEADLE MOORE, LLC AS AUDITORS | 87,721,382 | 71.77% | 0.00% | 3,270,719 | 2.68% | |
| Quorum: | 71.77% | |||||
| Total O/S | 122,231,109 |
A quorum of 87,721,382 shares were present at the meeting in person or by proxy, representing 71.77% of the Company’s outstanding voting shares.
About VYSTAR CORPORATION (OTCMKTS:VYST)
Vystar Corporation is the creator and owner of the technology to produce Vytex Natural Rubber Latex (NRL). The Company’s technology reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The Company operates in two segments: Vytex Division and Kiron Division. The Vytex Division is focused on expanding the licensing and utilization of its source natural rubber latex technology. Its Kiron Division provides sleep medicine services, including clinical and diagnostic. The Company’s products and services include Natural Rubber Latex, and Clinical Sleep Diagnostics and Durable Medical Equipment. Its product portfolio includes Vytex NRL in high ammonia (HA) and low ammonia (LA) formulations. Vytex NRL is produced at the latex processor level and can be integrated into the processing environments. Vytex NRL is produced at the latex processor level and can be integrated into various processing environments.